CANCER
Personal mRNA vaccine for melanoma begins final trial
The world’s first personalised mRNA cancer vaccine for melanoma is beginning phase 3 trials in hundreds of patients, as experts hailed its “gamechanging” potential to permanently cure cancer.
Melanoma affects about 132,000 people a year and is the biggest skin